Dan Adams—Bugher Foundation Champion for Training and Collaboration
Cerebral Microbleeds and Thrombolysis-Associated Intracerebral Hemorrhage
Genetic Architecture of Lacunar Stroke
Long-Term Blood–Brain Barrier Permeability Changes in Binswanger Disease
Elevated Total Homocysteine Levels in Acute Ischemic Stroke Are Associated With Long-Term Mortality
Copeptin Levels in Patients With Acute Ischemic Stroke and Stroke Mimics
Patients With Ischemic Stroke and Incident Atrial Fibrillation
Role of Acute Lesion Topography in Initial Ischemic Stroke Severity and Long-Term Functional Outcomes
Remote Ischemic Conditioning Alters Methylation and Expression of Cell Cycle Genes in Aneurysmal Subarachnoid Hemorrhage
Clipping and Coiling of Unruptured Intracranial Aneurysms Among Medicare Beneficiaries, 2000 to 2010
Microbleed Status and 3-Month Outcome After Intravenous Thrombolysis in 717 Patients With Acute Ischemic Stroke
High-Resolution Intracranial Pressure Burden and Outcome in Subarachnoid Hemorrhage
Accuracy of the ABC/2 Score for Intracerebral Hemorrhage
Risk Factors of Ischemic Stroke and Subsequent Outcome in Patients Receiving Hemodialysis
Prognostic Significance of Short-Term Blood Pressure Variability in Acute Stroke
Recurrent Stroke
Rate of Contrast Extravasation on Computed Tomographic Angiography Predicts Hematoma Expansion and Mortality in Primary Intracerebral Hemorrhage
Intracranial Carotid Calcification on Cranial Computed Tomography
Younger Stroke Patients With Large Pretreatment Diffusion-Weighted Imaging Lesions May Benefit From Endovascular Treatment
Combined Multimodal Computed Tomography Score Correlates With Futile Recanalization After Thrombectomy in Patients With Acute Stroke
Residual Risk of Stroke and Death in Anticoagulated Patients According to the Type of Atrial Fibrillation
Combined Approach to Lysis Utilizing Eptifibatide and Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke-Full Dose Regimen Stroke Trial
Clinical Implications of Changes in Individual Platelet Reactivity to Aspirin Over Time in Acute Ischemic Stroke
Low-Versus Standard-Dose Alteplase for Ischemic Strokes Within 4.5 Hours
Safety and Tolerability of Desmoteplase Within 3 to 9 Hours After Symptoms Onset in Japanese Patients With Ischemic Stroke
Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation
Do Patient Characteristics Explain the Differences in Outcome Between Medically Treated Patients in SAMMPRIS and WASID?
Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke
Deferoxamine, Cerebrovascular Hemodynamics, and Vascular Aging
Spouses of Stroke Survivors Report Reduced Health-Related Quality of Life Even in Long-Term Follow-Up
Cost-Utility Analysis of Mechanical Thrombectomy Using Stent Retrievers in Acute Ischemic Stroke
Neurorestorative Therapy of Stroke in Type 2 Diabetes Mellitus Rats Treated With Human Umbilical Cord Blood Cells
Role of Neurexin-1β and Neuroligin-1 in Cognitive Dysfunction After Subarachnoid Hemorrhage in Rats
Intravenous Bone Marrow Stem Cell Grafts Preferentially Migrate to Spleen and Abrogate Chronic Inflammation in Stroke
Rosiglitazone Promotes White Matter Integrity and Long-Term Functional Recovery After Focal Cerebral Ischemia
Activation of Dopamine D2 Receptor Suppresses Neuroinflammation Through αB-Crystalline by Inhibition of NF-κB Nuclear Translocation in Experimental ICH Mice Model
Recombinant ADAMTS 13 Attenuates Brain Injury After Intracerebral Hemorrhage
Vascular Neurologists as Directors of Stroke Centers in the United States
Cavernous Sinus Thrombosis in Children
White Matter Hyperintensities Relate to Clinical Progression in Subjective Cognitive Decline
Altered Fibrin Clot Properties in Patients With Cerebral Venous Sinus Thrombosis
Increase in [18F]-Fluoroacetate Uptake in Patients With Chronic Hemodynamic Cerebral Ischemia
Stroke and Neurodegeneration Induce Different Connectivity Aberrations in the Insula
Hypotension During Endovascular Treatment of Ischemic Stroke Is a Risk Factor for Poor Neurological Outcome
Safety of Statin Pretreatment in Intravenous Thrombolysis for Acute Ischemic Stroke
Dabigatran Therapy in Acute Ischemic Stroke Patients Without Atrial Fibrillation
Occurrence and Predictors of Falls in People With Stroke
Effects of Postconditioning on Neurogenesis and Angiogenesis During the Recovery Phase After Focal Cerebral Ischemia
Outcome Following Decompressive Hemicraniectomy for Malignant Cerebral Infarction
Minimally Invasive Microsurgery for Cerebral Aneurysms
Treatment Concepts for Wake-Up Stroke and Stroke With Unknown Time of Symptom Onset
Palliative Care
Temperature Management and Nursing Care of the Patient With Acute Ischemic Stroke
Stroke Literature Synopses
Inflammatory Cerebral Amyloid Angiopathy, Amyloid-β–Related Angiitis, and Primary Angiitis of the Central Nervous System
Organizational Update
Letter by van Klei and Dieleman Regarding Article, “Type of Anesthesia and Differences in Clinical Outcome After Intra-Arterial Treatment for Ischemic Stroke”
Letter by Campbell and Short Regarding Article, “Type of Anesthesia and Differences in Clinical Outcome After Intra-Arterial Treatment for Ischemic Stroke”
Response to Letter Regarding Article, “Type of Anesthesia and Differences in Clinical Outcome After Intra-Arterial Treatment for Ischemic Stroke”
Letter by Rebello et al Regarding Article, “Cryptic Loss of Consciousness in a 36-Year-Old Woman”
Response to Letter Regarding Article, “Cryptic Loss of Consciousness in a 36-Year-Old Woman”
Letter by Spence Regarding Article, “Diet and Stroke